Skip to main content
Caplight Logo









Alterbiotix

Alterbiotix

Private
BernHealthcare & Life Scienceshttps://alterbiotix.ch

Last Round

Convertible Debt

Sep 18, 2025

Total Funding Raised

$62,750

Company Overview

Alterbiotix operates in Healthcare & Life Sciences and is based in Bern. Its latest recorded funding round was a Convertible Debt round in September 2025.

Alterbiotix is a biotechnology company developing first-in-class peptide therapeutics designed to treat Streptococcus pneumoniae infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Alterbiotix Comparables

Compare Alterbiotix with similar companies based on industry and business-model similarity.

Alterbiotix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Helperby Therapeutics
70%
Clarametyx Biosciences
70%
PhalconBio GmbH
65%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Alterbiotix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtSep 18, 2025
GrantJun 24, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Alterbiotix Investors

Notable investors and investment history

Alterbiotix investors
InvestorRounds
INCATEConvertible Debt, Grant
Venture KickConvertible Debt, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2025

    $50K raised from INCATE and Venture Kick.

  • Jun 24, 2025

    $12K grant round from INCATE and Venture Kick.

Book a demo to see all signals

For institutional investors. Book with your work email.

Alterbiotix Filings

Explore SEC and related filing metadata, where available.

Alterbiotix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Alterbiotix's valuation, stock price, and market status.

Is Alterbiotix a public or private company?

Alterbiotix is a private company.

What is the current stock price of Alterbiotix?

Alterbiotix is a private company, so its shares have no public market price. Caplight tracks Alterbiotix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Alterbiotix worth (valuation)?

Valuation information for Alterbiotix is not publicly available.

Can I buy Alterbiotix stock?

Alterbiotix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Alterbiotix's last funding round?

Alterbiotix's most recent funding round was Convertible Debt on September 18, 2025.

Who are the main investors in Alterbiotix?

Key investors in Alterbiotix include INCATE, Venture Kick.

Will Alterbiotix IPO soon?

No public IPO plans have been announced for Alterbiotix.

How can I track Alterbiotix secondary market activity?

Caplight tracks bids, offers, and trades in Alterbiotix's shares on secondary markets.

Firmographic Details

HeadquartersBern
Employee Range1
Year Founded2025
Last FundingSep 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?